Semkovska M, Quinlivan L, O’Grady T, Johnson R, Collins A, O’Connor J et al (2019) Cognitive function following a major depressive episode: a systematic review and meta-analysis. Lancet Psychiatry 6:851–861
Murrough JW, Iacoviello B, Neumeister A, Charney DS, Iosifescu DV (2011) Cognitive dysfunction in depression: neurocircuitry and new therapeutic strategies. Neurobiol Learn Mem 96:553–563
Article CAS PubMed Google Scholar
Hasselbalch BJ, Knorr U, Hasselbalch SG, Gade A, Kessing LV (2012) Cognitive deficits in the remitted state of unipolar depressive disorder. Neuropsychology 26:642–651
Marx EM, Williams JM, Claridge GC (1992) Depression and social problem solving. J Abnorm Psychol 101:78–86
Article CAS PubMed Google Scholar
Disner SG, Beevers CG, Haigh EA, Beck AT (2011) Neural mechanisms of the cognitive model of depression. Nat Rev Neurosci 12:467–477
Article CAS PubMed Google Scholar
Yang XH, Huang J, Zhu CY, Wang YF, Cheung EF, Chan RC et al (2014) Motivational deficits in effort-based decision making in individuals with subsyndromal depression, first-episode and remitted depression patients. Psychiatry Res 220:874–882
Prévot T, Sibille E (2021) Altered GABA-mediated information processing and cognitive dysfunctions in depression and other brain disorders. Mol Psychiatry 26(1):151–167
Haroon E, Miller AH, Sanacora G (2017) Inflammation, glutamate, and glia: a trio of trouble in mood disorders. Neuropsychopharmacol 42:193–215
Capuron L, Miller AH (2011) Immune system to brain signaling: neuropsychopharmacological implications. Pharm Ther 130:226–238
Neto FL, Borges G, Torres-Sanchez S, Mico JA, Berrocoso E (2011) Neurotrophins role in depression neurobiology: a review of basic and clinical evidence. Curr Neuropharmacol 9:530–552
Article CAS PubMed PubMed Central Google Scholar
Fee C, Banasr M, Sibille E (2017) Somatostatin-positive gamma-aminobutyric acid interneuron deficits in depression: cortical microcircuit and therapeutic perspectives. Biol Psychiatry 82:549–559
Article CAS PubMed PubMed Central Google Scholar
Martinowich K, Lu B (2008) Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacol 33:73–83
Diehl DJ, Gershon S (1992) The role of dopamine in mood disorders. Compr Psychiatry 33:115–120
Article CAS PubMed Google Scholar
Bender DA (1983) Effects of a dietary excess of leucine on the metabolism of tryptophan in the rat: a mechanism for the pellagragenic action of leucine. Br J Nutr 50(1):25–32
Article CAS PubMed Google Scholar
Savitz J (2020) The kynurenine pathway: a finger in every pie. Mol Psychiatry 25(1):131–147
Kanai M, Funakoshi H, Takahashi H, Hayakawa T, Mizuno S, Matsumoto K et al (2009) Tryptophan 2,3-dioxygenase is a key modulator of physiological neurogenesis and anxiety-related behavior in mice. Mol Brain 2:8
Article PubMed PubMed Central Google Scholar
Fukunaga M, Yamamoto Y, Kawasoe M, Arioka Y, Murakami Y, Hoshi M et al (2012) Studies on tissue and cellular distribution of indoleamine 2,3-dioxygenase 2: the absence of IDO1 upregulates IDO2 expression in the epididymis. J Histochem Cytochem 60(11):854–860
Article PubMed PubMed Central Google Scholar
Connor TJ, Starr N, O’Sullivan JB, Harkin A (2008) Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma? Neurosci Lett 441(1):29–34
Article CAS PubMed Google Scholar
Molteni R, Macchi F, Zecchillo C, Dell’agli M, Colombo E, Calabrese F et al (2013) Modulation of the inflammatory response in rats chronically treated with the antidepressant agomelatine. Eur Neuropsychopharmacol 23(11):1645–1655
Article CAS PubMed Google Scholar
Cervenka I, Agudelo LZ, Ruas JL (2017) Kynurenines: tryptophan’s metabolites in exercise, inflammation, and mental health. Science 357(6349):eaaf9794
Foster AC, Vezzani A, French ED, Schwarcz R (1984) Kynurenic acid blocks neurotoxicity and seizures induced in rats by the related brain metabolite quinolinic acid. Neurosci Lett 48(3):273–278
Article CAS PubMed Google Scholar
Guillemin GJ (2012) Quinolinic acid, the inescapable neurotoxin. Febs J 279(8):1356–1365
Article CAS PubMed Google Scholar
Kaindl AM, Degos V, Peineau S, Gouadon E, Chhor V, Loron G et al (2012) Activation of microglial N-methyl-D-aspartate receptors triggers inflammation and neuronal cell death in the developing and mature brain. Ann Neurol 72(4):536–549
Article CAS PubMed Google Scholar
Stone TW, Perkins MN (1981) Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur J Pharmacol 72(4):411–412
Article CAS PubMed Google Scholar
Guillemin GJ, Croitoru-Lamoury J, Dormont D, Armati PJ, Brew BJ (2003) Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes. Glia 41(4):371–381
Kita T, Morrison PF, Heyes MP, Markey SP (2002) Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain. J Neurochem 82(2):258–268
Article CAS PubMed Google Scholar
Moffett JR, Namboodiri MA (2003) Tryptophan and the immune response. Immunol Cell Biol 81(4):247–265
Article CAS PubMed Google Scholar
Tufvesson-Alm M, Imbeault S, Liu XC, Zheng Y, Faka A, Choi DS, Schwieler L, Engberg G, Erhardt S (2020) Repeated administration of LPS exaggerates amphetamine-induced locomotor response and causes learning deficits in mice. J Neuroimmunol 349:577401
Article CAS PubMed Google Scholar
Schwarcz R, Bruno JP, Muchowski PJ, Wu H-Q (2012) Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13(7):465–477
Article CAS PubMed PubMed Central Google Scholar
Oliveros A, Wininger K, Sens J, Larsson MK, Liu XC, Choi S et al (2017) LPS-induced cortical kynurenic acid and neurogranin-NFAT signaling is associated with deficits in stimulus processing during pavlovian conditioning. J Neuroimmunol 313:1–9
Article CAS PubMed PubMed Central Google Scholar
Imbeault S, Goiny M, Liu X, Erhardt S (2020) Effects of IDO1 and TDO2 inhibition on cognitive deficits and anxiety following LPS-induced neuroinflammation. Acta Neuropsychiatr 32(1):43–53
Gulaj E, Pawlak K, Bien B et al (2010) Kynurenine and its metabolites in Alzheimer’s disease patients. Adv Med Sci 55(2):204–211. https://doi.org/10.2478/v10039-010-0023-6
Article CAS PubMed Google Scholar
Bonda DJ, Mailankot M, Stone JG et al (2010) Indoleamine 2,3-dioxygenase and 3- hydroxykynurenine modifications are found in the neuropathology of Alzheimer’s disease. Redox Rep 15(4):161–168. https://doi.org/10.1179/174329210X12650506623645
Article CAS PubMed Google Scholar
Guillemin GJ, Brew B, Noonan C et al (2005) Indoleamine 2, 3 dioxygenase and QUIN immunoreactivity in Alzheimer’s disease hippocampus. Neuropathol App Neurobiol 31(4):395–404
Marcinkowska M, Mordyl B, Fajkis-Zajaczkowska N, Siwek A, Karcz T, Gawalska A, Bucki A, Żmudzki P, Partyka A, Jastrzębska-Więsek M, Pomierny B, Walczak M, Smolik M, Pytka K, Mika K, Kotańska M, Kolaczkowski M (2023) Hybrid molecules combining GABA-A and serotonin 5-HT6 receptors activity designed to tackle neuroinflammation associated with depression. Eur J Med Chem 247:115071
Article CAS PubMed Google Scholar
Rao SK, Andrade C, Reddy K, Madappa KN, Thyagarajan S, Chandra S (2002) Memory protective effect of indomethacin against electroconvulsive shock-induced retrograde amnesia in rats. Biol Psychiatry 51:770–773
Article CAS PubMed Google Scholar
Kumar A, Rani A, Scheinert RB, Ormerod BK, Foster TC (2018) Nonsteroidal anti-inflammatory drug, indomethacin improves spatial memory and NMDA receptor function in aged animals. Neurobiol Aging 70:184
留言 (0)